Skip to Main Content

Paper Details

Sorafenib or placebo in patients with newly diagnosed acute myeloid leukaemia: long-term follow-up of the randomized controlled SORAML trial.
Leukemia
37
2021
Author NameAffiliation
Christoph R??lligUniversitatsklinikum der Technischen Universitat Dresden
Wolfgang E BerdelUniversitatsklinikum Munster
  • 1 - 2

Datasets

Release 1.2